Chronolife is a digital health company committed to developing innovative mobile solutions for remote monitoring services.

Core Values:
Achieve Excellence

Our core innovation is based on a patented neuromorphic (bio-mimetic) algorithm , HOTS (Hierarchy Of event-based Time-Surfaces), that detects and predicts deterioration in state of health of patients and alerts care givers to allow earlier intervention and avoid costly hospitalizations.

Chronolife has also developed a patented smart t-shirt capable of capturing 6 different physiological parameters paving the way for continuous remote monitoring through easy to use everyday garment.


Our vision:

To be at the fore front of developing highly innovative digital health solutions paired with predictive algorithm.

Our mission:

To enable healthcare professionals to have timely information for earlier intervention and to ensure a continuum of care that fills the existing gaps from hospital to home.

Laurent Vandebrouck
CEO of Chronolife

Before joining Chronolife, Laurent set up and grew Qualcomm Life in Europe between 2012 and 2018, Qualcomm Life being an enabler and connectivity provider for connected and Digital Health services globally.

Prior to Qualcomm Life, Laurent developed, launched and managed different new businesses and P&L for the enterprise market in B2B mode for leading satellite operators such as Eutelsat and for leading wireless communication technology providers such as Qualcomm.

His expertise is therefore focused on the development and operation of end-to-end services leveraging innovative satellite, cellular, IoT and Cloud based technologies applied to the enterprise market in general and to Digital Health in particular.



  • Raphaël Brunschvig
    Sales Manager DACH
  • Maxime Cervino
    Sales Manager Southern Europe
  • Pierre Tran
    Senior Full Stack Developer
  • Flora Maurincomme
    Sales Manager Nordics
  • Dr Birgit Assmus
    Head of Cardiology Department and of Interdisciplinary Center of Heart Failure
    Goethe University Frankfurt
  • LAV
    Laurent Vandebrouck
    Chief Executive Officer
  • Soizic Fleury
    Marketing Director
  • James Pyers
    Managing Director, North America
  • Dominique Dury
    Clinical Operation Manager
  • Michel Clet
    Engineering SW/FW & Data Science Director
  • Dr Marc Salomon
    Medical Director
  • Aline Bertaud
    Office Manager
  • PHP
    Paul-Henri Prévot
    Program Manager (PhD)
  • GiC
    Gilles Cordurie
    Hardware Designer (PhD)
  • ILL
    Ilhème Lamouri
    Electronic Technician
  • CLM
    Claire Marin
    Data Scientist
  • HAR
    Harmony Roger
    Textile Manager
  • Emma Bertin
    Marketing Manager
  • TIA
    Tiana Andriamiandrisoa
    Quality, Operations & Regulatory Director
  • LUR
    Ludovic Remond
    Quality & Production Specialist
  • Marion Kervella
    Regulatory Specialist
  • Dr Laurent Sebbag
    Dr Laurent Sebbag (Chair)
    Head of Heart Failure and Transplant Department
    Hopital Louis Pradel
    59 Boulevard Pinel
    69500 Bron
  • Dr Peter Karl Jacobsen
    Dr Peter Karl Jacobsen
    Director of Arrhythmia Service
    Department of Cardiology, The Heart Center, University of Copenhagen
    Rigshospitalet, Blegdamsvej 9
    2300 København Ø
  • Dr Kasper Rossing
    Dr Kasper Rossing
    Department of Cardiology, The Heart Center, University of Copenhagen
    Rigshospitalet, Blegdamsvej 9
    2300 København Ø
  • Dr Thierry Dantoine
    Dr Thierry Dantoine
    Head of Geriatric Medicine
    Centre hospitalier universitaire de Limoges
    2 Avenue Martin Luther King,
    87000 Limoges
  • Dr Fadi Jamal
    Dr Fadi Jamal
    155 Ter, Boulevard Stalingrad
    69006 LYON
  • Dr Marcel Garrigou-Grandchamp
    Dr Marcel Garrigou-Grandchamp
    General Practitioner
    56 Rue Jeanne d'Arc
    69003 Lyon
  • BG
    Bernard Gilly
    Founder & chairman of several successful disruptive biotech & medtech companies: Tilak Healthcare, Chronolife, Prophesee, Gecko Biomedical, GenSight Biologics , Pixium Vision, Enterome, Fovea Pharmaceuticals (acquired by Sanofi). Previously Managing Partner at Sofinnova Partners (Paris), Chairman & CEO of Transgene, VP R&D at BioMerieux.
  • AP
    Alexia Perouse
    Successful lead/co-lead investor in 10+ innovative HealthTech start-ups, from Series A to exit. Head of Healthcare VC at Omnes Capital. Spin-off of Credit Agricole Private Equity in 2012 - € 330m AUM in venture capital. Active role as a member of the board of directors and committees (remco, audit, strategy). Involved in 8 M&A and IPOs, Investment Manager in Sofinnova Partners.
  • DJO
    Donald Jones
    Donald Jones serves as an independant board member for venture backed health companies and on Fortune 1000 Digital Health Advisory Boards. His expertise is in growing digital heath, digital therapeutics and technology enabled health services. He is globally recognized for his digital transformation expertise.
  • BCE
    Bruno Cervera
    Bruno manages Passage de l’Innovation, startup studio of the iBionext ecosystem. He is specialized in administrative and financial time-share management with project leaders and innovative companies in the field of biotech/medtech. He is also specialized in IPO preparations and has participated in 6 IPOs.
  • Adrea
  • Dimitri Boulanger
    Dimitri runs the single family office Celeste Management, based in Geneva, Switzerland. Celeste invests across multiple alternative asset classes in private equity, venture, infrastructure, real estate and private debt. Celeste has invested in several start ups especially in the health space.
  • Fernando Romao
    Engineering HW & Manufacturing Director
  • Denis Fendt
    Denis Fendt is Vice President and Director of Development of the Aesio Group. Actuary by training, Denis has spent his entire career in the world of insurance. He held technical, financial and commercial positions in the AXA, Mercer and Swisslife groups before joining Aésio in November 2016.